An in vitro enzyme activity assay for wild type IDH1 was performed as previously described (8 (link)). In brief, 20 ng purified IDH1 and YF variant proteins that were pre-treated with or without recombinant active tyrosine kinases in an in vitro kinase assay were added to 100 μl enzyme activity assay buffer (25mM Tris-HCl (pH7.5), 10 mM MgCl2, 5 mM DTT) containing 0.5 mM NADP+ (Sigma-Aldrich) and 1 mM isocitric acid (Sigma-Aldrich). To determine the wild type IDH1 activity in cells, endogenous IDH1 from 1×107 cells was bound to protein G-Sepharose 4 Fast Flow beads (Sigma-Aldrich) by immunoprecipitation using IDH1 antibody (CST). To test IDH1 activity in xenograft tumor tissues, around 2 mg of total tumor lysates were used. After immunoprecipitation, the IDH1-bound beads were washed 3 times and eluted using IDH1 peptide (CST). Then 10 ul of the supernatant was added to 100μl assay buffer (25mM Tris-HCl, pH7.5, 10 mM MgCl2, 5 mM DTT) containing 0.5 mM NADP+ and 1 mM isocitric acid. IDH1 activity was measured by recording absorbance of 340 nm in kinetic mode every 20 seconds for 15 minutes using a SpectraMax Plus spectrophotometer (Molecular Devices).